Urology

Journal of the American College of Surgeons

Volumn 190, Issue 2, 2000, Pages 244-252

  Menon, Mani ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SILDENAFIL;

BLADDER CANCER; CANCER MORTALITY; CIRCUMCISION; CRYOSURGERY; DISEASE ASSOCIATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; NEPHRECTOMY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; RENOVASCULAR HYPERTENSION; REVIEW; SEXUAL DYSFUNCTION; SURGICAL TECHNIQUE; URINARY TRACT INFECTION; UROLITHIASIS; UROLOGIC SURGERY;

EID: 0033970469     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00275-6     Document Type: Article

References (27)

1. Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report. J Urol 1991;146:278-282.
2. Gill IS, Rassweiler JJ. Retroperitoneoscopic renal surgery: our approach. Urology 1999;54:734-738.
3. Gill IS, Novick AC, Soble JJ, et al. Laparoscopic renal cryoablation: initial clinical series. Urology 1998;52:543-551.
4. Nogueira JM, Cangro CB, Fink JC, et al. A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. Transplantation 1999;67:722-728.
5. Guillonneau B, Vallancien G. Laparoscopic radical prostatectomy: initial experience and preliminary assessment after 65 operations. Prostate 1999;39:71-75.
6. Gronberg H, Xu J, Smith JR, et al. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res 1997;57: 4707-4709.
7. Gronberg H, Isaacs SD, Smith JR, et al. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 1997;278:1251-1255.
8. Gronberg H, Smith J, Emanuelsson M, et al. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. Am J Hum Genet 1999;65:134-140.
9. Xu J, Meyers D, Freije D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20: 175-179.
10. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
11. Lee BR, Roberts WW, Smith DG, et al. Bioimpedance: novel use of a minimally invasive technique for cancer localization in the intact prostate. Prostate 1999;39:213-218.
12. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998;280:975-980.
13. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999:281:1591-1597.
14. Jønler M, Nielsen OS, WolfH. Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment. Urology 1998;52:1055-1062.
15. Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999;85:2460-2468.
16. Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999; 17:517-522.
17. Freytag SO, Rogulski KR, Paielli DL, et al. A novel threepronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. Hum Gene Ther 1998;9:1323-1333.
18. Landman J, Chang Y, Kavaler E, et al. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology 1998;52:398-402.
19. Simons JW, Mikhak B. Ex-vivo gene therapy using cytokinetransduced tumor vaccines: molecular and clinical pharmacology. Semin Oncol 1998;25:661-676.
20. Seigne J, Turner J, Diaz J, et al. A feasibility study of gene gun mediated immunotherapy for renal cell carcinoma. J Urol 1999; 162:1259-1263.
21. Simons JW, Mikhak B, Chang JF, et al. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. Cancer Res 1999;59:5160-5168.
22. Tamayo P, Slonim D, Mesirov J, et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999;96:2907-2912.
23. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine Induces cancer progression by a cell-autonomous mechanism. Nature 1999;397:530-534.
24. Del Pizzo JJ, Jacobs SC, Sklar GN. Ureteroscopic evaluation in renal transplant recipients. J Endourol 1998;12:135-138.
25. Lowentritt BH, Scardino PT, Miles BJ, et al. Sildenafil citrate after radical retropubic prostatectomy. J Urol 1999;162:1614-1617.
26. Sidhu H, Hoppe B, Hesse A, et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 1998;352:1026-1029.
27. To T, Agha M, Dick PT, Feldman W. Cohort study on circumcision of newborn boys and subsequent risk of urinary-tract infection. Lancet 1998;352:1813-1816.